Saw palmetto Serenoa repens (W.Bartram) Small
Also called: American dwarf palm tree, cabbage palm, Sabal serrulata, Serenoa serrulata
Saw palmetto is a small palm, 6 to 10 feet tall, native to the West Indies and the southeast coast of North America. Its berries (fruit) are used, as extracts.
- Category
- Botanical
- Part used
- Berries (fruit)
- Strongest evidence
- C Limited
- Reviewed
- 2026-10-28
Class 1 Well studied in people. A 2023 Cochrane review included 27 RCTs (4,656 participants with benign prostatic enlargement); 19 compared Serenoa repens alone with placebo and 8 tested it in combination with other plant agents. [3]
Fact-checked 2026-10-28 · How this guide is made
Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.
What research has studied
Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.
CHormones and reproduction3 topics
CSkin and hair1 topic
A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials
| Topic studied | Grade | What the evidence shows |
|---|---|---|
| Urinary symptoms of benign prostatic enlargement (BPH) | X | Cochrane (2023): 27 studies, 4,656 participants; saw palmetto alone made little to no difference in symptoms or quality of life at 3 to 6 and 12 to 17 months (high-certainty evidence). [3] |
| Hexane-extracted versus other products for BPH | X | Reviewers analyzed hexane-extracted products separately and found no difference in effect on BPH symptoms. [1] |
| Chronic prostatitis/chronic pelvic pain syndrome | C | A 2022 review of five studies did not find a significant benefit. [1] |
| Male-pattern hair loss | C | A few small oral or scalp-applied studies; NCCIH states the evidence is too limited for conclusions. [1] |
Main constituents: Volatile oils and free fatty acids are believed to be the active components [2]
Amounts studied and limits
Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.
- Trial doses cited by LiverTox include 160 mg twice daily (one-year trial in men with BPH) and 320 mg once daily (long-term study). [2]
No official upper intake level has been set.
Safety and side effects
- Liver (NIH LiverTox)Score DABCDEA: well known causeE: unlikely cause
LiverTox likelihood score D: possible, rare cause of clinically apparent liver injury (chapter last updated April 2, 2020).
Details and sources - Pregnancy and breastfeedingEU herbal monograph: pregnancy and lactation "not relevant"; no fertility data available.
2 statements in the profile.
Details and sources - Interactions with medicines2 listed
Warfarin; CYP450 inducers or inhibitors
Details and sources - Cancer evaluations (IARC, NTP)None found
No IARC or NTP evaluation was found in the lists checked.
Details and sources - FDA new dietary ingredient notifications2 on FDA's list
FDA does not approve dietary supplements. Each entry is one party's filing.
Details and sources - Dose in official monographs2 statements
EU (HMPC monograph adopted 24 November 2015), well-established use, adults and elderly: hexane soft extract 320 mg once daily or 160 mg twice daily, …
Details and sources
- Well tolerated; used safely in studies for up to 3 years. Mild, infrequent effects may include digestive symptoms, dizziness and headache. [1]
- Does not appear to affect PSA readings, even at higher-than-usual amounts. [1]
- May be unsafe during pregnancy or breastfeeding. [1]
- LiverTox likelihood score D (possible, rare cause of clinically apparent liver injury); no fatal cases reported. [2]
Interactions
| With | What happens |
|---|---|
| Other medicines | LiverTox states saw palmetto has few herb-drug interactions. [2] |
Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.
Identity, quality and standardization
- Extraction solvent matters in EU assessments: hexane-extracted and ethanol-extracted fruit preparations are assessed under different evidence bases. [4]
Regulatory status
- US: herbal products for oral use are often marketed as dietary supplements, which, unlike drugs, are not approved by the FDA before sale; manufacturers are responsible for safety and labeling. [1]
- EU: an EU herbal monograph covers well-established use of hexane-extracted fruit for BPH symptoms and traditional use of ethanol-extracted fruit for related urinary symptoms in adult men. [4]
Safety, quality and supply profile
Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.
Compounds responsible
Compounds the sources name as the main or characteristic actives.
US status
What FDA's published records show. FDA does not approve dietary supplements.
- FDA's published NDI notification list has 2 entries naming saw palmetto (one spelled "Serena repens"), both in multi-ingredient combinations (earliest NDI 504 submitted 2007-12-03; most recent NDI 896 submitted 2015-11-16). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P4]
Cancer evaluations (IARC and NTP)
Evaluations name the exact material tested, which may differ from a supplement.
Liver (NIH LiverTox)
- LiverTox likelihood score D: possible, rare cause of clinically apparent liver injury (chapter last updated April 2, 2020). [P1]
Interactions with medicines
- Warfarin: EU herbal monograph: a few cases of suspected interactions with warfarin have been reported; increased INR values have been described. [P2]
- CYP450 inducers or inhibitors: LiverTox: saw palmetto has few herb-drug interactions and is not affected by inducers or inhibitors of the cytochrome P450 enzyme system. [P1]
Alcohol
- No published information found in the sources checked.
Interactions with other herbs and supplements
- No published information found in the sources checked.
Adulteration and substitution
- 2023 J Nat Prod review by authors from the ABC-AHP-NCNPR Botanical Adulterants Prevention Program: dilution or substitution of saw palmetto oil with palm, sunflower and coconut oil is reportedly quite common in years when the harvest is low; these mixtures can have a fatty acid profile indistinguishable from saw palmetto oil. The program's bulletin is Gafner S, Baggett S, Adulteration of saw palmetto (Serenoa repens) (2017). [P6]
- Fatty acids of animal origin were found to be widespread in commercial samples of saw palmetto oil; such designer blends are made to comply with current authentication assays. [P7]
- In a stable isotope study, the isotopic values of all 9 commercial saw palmetto extracts tested were outside the ranges of 20 authentic extracts and closer to meat fat and pure fatty acids. [P8]
What a certificate of analysis should cover
Tests a quality specification for this material would include, with the reason for each.
- Identity test of the dietary ingredient (at least one appropriate test or examination) — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petitioned under 111.75(a)(1)(ii). [P9]
- Fatty acid profile, with attention to linoleic and caprylic acid, plus acid value — Vegetable-oil adulteration can be detected by unusually large amounts of certain fatty acids (e.g. linoleic and caprylic acid); the acid value of saw palmetto is typically higher than that of other vegetable oils. [P6]
- 1H NMR (glycerol signals of triglycerides near 4.20 and 5.25 ppm) — These signals are much lower in saw palmetto than in some of its common adulterants. [P6]
- Stable isotope ratio analysis (bulk and fatty-acid δ13C, δ2H, δ18O) — Perini et al. 2019 propose stable isotope ratio analysis as a suitable tool for detecting adulteration in saw palmetto extracts; all 9 commercial extracts tested had values closer to meat fat and pure fatty acids than to authentic extracts. [P8]
- Compliance with Ph. Eur. monograph 1848 — The EU herbal monograph states the material complies with the Ph. Eur. monograph (ref. 1848). [P2]
Supply and conservation
Absorption in people
- EU herbal monograph (2015), pharmacokinetic properties: no data available. [P2]
Formulations studied to change absorption
Human data only.
- No published information found in the sources checked.
Dose in official monographs
As the monograph states it, for its jurisdiction; not personal advice.
- EU (HMPC monograph adopted 24 November 2015), well-established use, adults and elderly: hexane soft extract 320 mg once daily or 160 mg twice daily, oral; long-term use possible. [P2]
- EU (same monograph), traditional use, adults and elderly: ethanol (90–96% m/m) soft extract (DER 7.5-14.3:1) 320 mg once daily, oral. The monograph states there is no relevant indication for women, children and adolescents. [P2]
Sources for this profile
- NIH LiverTox (NIDDK). Saw Palmetto (Last Update: April 2, 2020), 2020-04-02. ncbi.nlm.nih.gov
- European Medicines Agency, HMPC. European Union herbal monograph on Serenoa repens (W. Bartram) Small, fructus (EMA/HMPC/280079/2013, adopted 24 November 2015), 2015-11-24. ema.europa.eu
- NCCIH. Saw Palmetto: Usefulness and Safety (Last Updated: April 2025), 2025-04. nccih.nih.gov
- FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
- IARC Monographs. List of Classifications (agents classified by the IARC Monographs; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
- Gafner S, Blumenthal M, Foster S, Cardellina JH 2nd, Khan IA, Upton R. Botanical Ingredient Forensics: Detection of Attempts to Deceive Commonly Used Analytical Methods for Authenticating Herbal Dietary and Food Ingredients and Supplements. J Nat Prod 2023;86(2):460-472 (American Chemical Society), 2023-02-24. pmc.ncbi.nlm.nih.gov
- Perini M, et al. Combined use of isotopic fingerprint and metabolomics analysis for the authentication of saw palmetto (Serenoa repens) extracts. Fitoterapia. 2018;127:15-19, 2018-06. pubmed.ncbi.nlm.nih.gov
- Perini M, et al. The use of stable isotope ratio analysis to characterize saw palmetto (Serenoa repens) extract. Food Chem. 2019;274:26-34, 2019-02-15. pubmed.ncbi.nlm.nih.gov
- eCFR. 21 CFR 111.75 What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
- GBIF species API: IUCN Red List category for Serenoa repens (W.Bartram) Small, 2026-10-29. api.gbif.org
- National Toxicology Program (NIEHS). Technical Reports list (checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
Sources
- NCCIH. Saw Palmetto: Usefulness and Safety (Last Updated: 2025-04), 2025-04. nccih.nih.gov
- NIH LiverTox (NIDDK). Saw Palmetto (Last Update: 2020-04-02), 2020-04-02. ncbi.nlm.nih.gov
- Cochrane Database of Systematic Reviews. Franco JV, Trivisonno L, Sgarbossa NJ, et al. Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement. 2023;6(6):CD001423 (PubMed abstract, PMID 37345871), 2023-06-22. pubmed.ncbi.nlm.nih.gov
- European Medicines Agency, HMPC. Sabalis serrulatae fructus (saw palmetto fruit) - herbal medicinal product, 2016-04-28. ema.europa.eu
- A
- Consistent results from several randomized trials or a systematic review of them
- B
- Some positive randomized trials, but small, short, few or inconsistent
- C
- Limited human evidence: single small trials, observational data or mixed results
- D
- Laboratory or animal evidence only; not shown in people
- X
- Well-designed human trials found no meaningful effect
More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement
Health information notice
These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.
Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.
EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.